A Comparison of Rheumatoid Arthritis Patients in Kuwait with Other Populations: Results from the KRRD Registry

References (56)

1. 1 The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. [DOI]
2. 2 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative [DOI]
3. 3 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls [DOI]
4. 4 Constructing validity: Basic issues in objective scale development. [DOI]
5. 5 High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors [DOI]
6. 6 Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins [DOI]
7. 7 The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study [DOI]
8. 8 Smoking and Cardiovascular Disease [DOI]
9. 9 Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) [DOI]
10. 10 THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS [DOI]
11. 11 Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
12. 12 The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century [DOI]
13. 13 Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register [DOI]
14. 14 Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty‐year period [DOI]
15. 15 Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study [DOI]
16. 16 Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) [DOI]
17. 17 Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis.
18. 18 Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists [DOI]
19. 19 Smoking Intensity, Duration, and Cessation, and the Risk of Rheumatoid Arthritis in Women [DOI]
20. 20 Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? [DOI]
21. 21 Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studies [DOI]
22. 22 Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis [DOI]
23. 23 British Society for Rheumatology Biologics Register [DOI]
24. 24 Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions [DOI]
25. 25 Epidemiology of smoking among Kuwaiti adults: prevalence, characteristics, and attitudes.
26. 26 A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis [DOI]
27. 27 Higher Rates and Clustering of Abnormal Lipids, Obesity, and Diabetes Mellitus in Psoriatic Arthritis Compared With Rheumatoid Arthritis [DOI]
28. 28 The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank [DOI]
29. 29 Worldwide research productivity in the field of rheumatology from 1996 to 2010: a bibliometric analysis [DOI]
30. 30 Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors [DOI]
31. 31 Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis [DOI]
32. 32 Association of Anti‐Cyclic Citrullinated Peptide Antibodies, Anti‐Citrullin Antibodies, and IgM and IgA Rheumatoid Factors with Serological Parameters of Disease Activity in Rheumatoid Arthritis [DOI]
33. 33 Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis [DOI]
34. 34 SPSS for Windows: An introduction To Use and interpretation in Research
35. 35 Effects of Smoking and Shared Epitope on the Production of Anti–Citrullinated Peptide Antibody in a Japanese Adult Population [DOI]
36. 36 The CORRONA database [DOI]
37. 37 Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts [DOI]
38. 38 Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort [DOI]
39. 39 Has the Severity of Rheumatoid Arthritis at Presentation Diminished Over Time? [DOI]
40. 40 A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis [DOI]
41. 41 Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis [DOI]
42. 42 Cardiovascular Disease and Rheumatoid Arthritis: An Update [DOI]
43. 43 Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis [DOI]
44. 44 Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis [DOI]
45. 45 Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis [DOI]
46. 46 Gene–environmental interaction between smoking and shared epitope on the development of anti‐cyclic citrullinated peptide antibodies in rheumatoid arthritis: a meta‐analysis [DOI]
47. 47 Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
48. 48 Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalizations in Sweden between 1973 and 2004 [DOI]
49. 49 Hypertension in kuwait: the past, present and future.
50. 50 Prevalence of thyroid dysfunction in patients with rheumatoid arthritis [DOI]
51. 51 Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases [DOI]
52. 52 Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis [DOI]
53. 53 Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study [DOI]
54. 54 Incidence of musculoskeletal pain in adult Kuwaitis using the validated Arabic version of the WHO-ILAR COPCORD Core Questionnaire [DOI]
55. 55 Prevalence and distribution of autoimmune diseases in 368 rheumatoid arthritis families.
56. 56 Baseline Population Survey Data on the Prevalence of Risk Factors for Coronary Artery Disease Among Kuwaitis Aged 15 Years and Older [DOI]

Cited by 25

Showing 7 of 25 known citations — external sources report more than can currently be individually listed.

Related research

• Assessment of Exclusive Breastfeeding Practice among Palestinian Mothers in the Gaza Strip: A Mixed Methods Design — shares topic coverage
• Impact of the Diet Profile and Alcohol Consumption on Cardiometabolic Risks in Dschang Health District-Cameroon — shares topic coverage
• The Prevalence, Risk Factors and Awareness of Hypertension in an Urban Population of Dehradun, Uttarakhand, India — shares topic coverage
• ABO Blood Groups and Malaria Prevalence in a Referral Hospital in Nigeria — shares topic coverage
• Prevalence of Malaria among Pregnant Women and Children Under Five Years in Abi Local Government Area, Cross River State, Nigeria — shares topic coverage